AstraZeneca Investors Rejoice After COPD Drug Performs in Phase IV Study Post author:Sam Post published:December 3, 2017 Post category:BioPharma Tudorza, also marketed as Eklira and Bretaris, is available in more than 50 countries. Source: BioSpace You Might Also Like Mitsubishi Tanabe Coughs Up $1.1 Billion Cash for This Parkinson's Biotech July 23, 2017 BrainLAB AG Snags FDA Win for Two New Indication-Specific Radiosurgery Software Applications September 20, 2017 OTEZLA® (Apremilast) Phase III Data Showed Significant Improvements in Patients with Active Behçe… February 18, 2018
BrainLAB AG Snags FDA Win for Two New Indication-Specific Radiosurgery Software Applications September 20, 2017
OTEZLA® (Apremilast) Phase III Data Showed Significant Improvements in Patients with Active Behçe… February 18, 2018
